The novel therapy of this peptide represents a major breakthrough in the management of the condition. Distinct from existing medications, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatidepeptide587910.bloginder.com/42638479/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment